Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a website help cancer patients avoid unwanted aggressive treatments?

NCT ID NCT07712237

Symptom relief Sponsor: Tri-Service General Hospital (TSGH) Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 17, 2026 · Last updated Jul 22, 2026 · Updated 2 times

Summary

This trial tests whether a web-based educational program can help people with advanced cancer reduce their preference for aggressive life-sustaining treatments. Participants are randomly assigned to receive either the web program plus an informational leaflet, or the leaflet alone. The study measures changes in treatment preferences through questionnaires at the start, right after the program, and one week later.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a web-based advance care planning educational program
What this could lead to
If effective, this web-based tool could help patients with advanced cancer make more informed decisions about their end-of-life care and reduce unwanted aggressive treatments.
What could go wrong
This is a small, early-stage trial with only 110 participants and a short follow-up of one week, so results may not apply broadly. The intervention relies on internet access, which may limit its reach.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

110 people

The number who actually took part.

Started

Oct 2023

Finished

Jan 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosed with advanced cancer (stage III or IV) * Aged 18 years or older * Able to communicate fluently in Mandarin Chinese or Taiwanese * Able and willing to provide informed consent * No cognitive impairment * Have access to Internet-connected electronic devices at home * Have not previously received advance care planning (ACP) consultation * Have not completed an advance directive (AD) Exclusion Criteria: * No access to Internet-connected electronic devices at home * Unable to operate Internet-based electronic devices * Previous participation in ACP consultation or completion of an AD * Cognitive impairment * Severe physical or psychological symptoms that would interfere with participation in the study * Concurrent participation in another intervention study * Refusal to participate

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Advanced cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Advanced cancer

Contacts and locations

Locations

  • Tri-Service General Hospital

    Taipei, Taipei City, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.